<code id='CE1086D927'></code><style id='CE1086D927'></style>
    • <acronym id='CE1086D927'></acronym>
      <center id='CE1086D927'><center id='CE1086D927'><tfoot id='CE1086D927'></tfoot></center><abbr id='CE1086D927'><dir id='CE1086D927'><tfoot id='CE1086D927'></tfoot><noframes id='CE1086D927'>

    • <optgroup id='CE1086D927'><strike id='CE1086D927'><sup id='CE1086D927'></sup></strike><code id='CE1086D927'></code></optgroup>
        1. <b id='CE1086D927'><label id='CE1086D927'><select id='CE1086D927'><dt id='CE1086D927'><span id='CE1086D927'></span></dt></select></label></b><u id='CE1086D927'></u>
          <i id='CE1086D927'><strike id='CE1086D927'><tt id='CE1086D927'><pre id='CE1086D927'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:16868
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Obesity drug from Roche shows promise in early study
          Obesity drug from Roche shows promise in early study

          SebastienBozon/AFPviaGettyImagesLONDON—RocheonThursdaysaiditsrecentlyacquiredexperimentalobesitymedi

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Investment in vaccine development is lagging, report finds

          AdobeCovidvaccinessavednearly20millionlivesworldwide,byoneestimate,andgeneratedbillionsofdollarsfors